Safeguard Scientifics Inc. (SFE, Financial) filed Quarterly Report for the period ended 2012-09-30.
Safeguard Scientifics, Inc. has a market cap of $333.8 million; its shares were traded at around $15.68 with and P/S ratio of 9.6.
Our partner companies depend upon their ability to attract and retain senior management and key personnel, including trained technical and marketing personnel. Our partner companies also will need to continue to hire additional personnel as they expand. At present, none of our partner companies have employees represented by labor unions. Although our partner companies have not been the subject of a work stoppage, any future work stoppage could have a material adverse effect on their respective operations. A shortage in the availability of the requisite qualified personnel or work stoppage would limit the ability of our partner companies to grow, to increase sales of their existing products and services, and to launch new products and services.
Read the The complete Report
Safeguard Scientifics, Inc. has a market cap of $333.8 million; its shares were traded at around $15.68 with and P/S ratio of 9.6.
Highlight of Business Operations:
Net cash provided by (used in) investing activities decreased by $5.6 million. The decrease primarily related to a $156.6 million decrease in proceeds from sales of and distributions from companies and funds, a $10.2 million increase in advances and loans to companies and a $1.8 million decrease in repayment of advances to companies, partially offset by a $53.0 million decrease in cash paid to acquire ownership interests in companies and funds and a $110.0 million net decrease in cash paid to acquire marketable securities. Proceeds from sales of and distributions from companies and funds in the nine months ended September 30, 2012 included $3.4 million and $5.6 million received in connection with expiration of the escrow period and achievement of the initial milestone associated with the Avid transaction as well as $1.9 million and $3.4 million received in connection with achievement of the milestones and expiration of the escrow period associated with the Portico transaction. The nine months ended September 30, 2011 included $137.9 million from the sale of Advanced BioHealing.Our partner companies depend upon their ability to attract and retain senior management and key personnel, including trained technical and marketing personnel. Our partner companies also will need to continue to hire additional personnel as they expand. At present, none of our partner companies have employees represented by labor unions. Although our partner companies have not been the subject of a work stoppage, any future work stoppage could have a material adverse effect on their respective operations. A shortage in the availability of the requisite qualified personnel or work stoppage would limit the ability of our partner companies to grow, to increase sales of their existing products and services, and to launch new products and services.
Read the The complete Report
